July 30, 2026 – Long-Term FUS Data for Prostate Cancer and more news…

Published: July 30, 2026

July 30, 2026

10-Year Evidence Published Supporting Focused Ultrasound as a Potential First Line Treatment for Prostate Cancer

Outcomes from 3,477 prostate cancer patients in the UK who were treated with focal therapy and followed for up to 10 years have now been published.
The findings represent one of the largest and longest evidence datasets in the field.

Focused Ultrasound in Psychiatry: Second PULSE Symposium Held in Toronto

Last month, researchers and clinicians gathered in Toronto for the second Focused Ultrasound in Psychiatry Symposium.
Attendees discussed the use of focused ultrasound neuromodulation for treating addiction, depression, anxiety, trauma-related disorders, and more.

Histotripsy for Liver Tumors Earns Regulatory Approval in Europe

HistoSonics’ Edison histotripsy system has been granted a CE Mark for the treatment of liver tumors.
The company plans to initiate a phased commercial rollout in Europe, beginning with select centers of excellence.

Podcast: Demystifying the Regulatory Landscape

Matt Myers, PhD, a research physicist who spent more than 30 years at the US Food and Drug Administration, shares his insights on evaluating emerging devices and applications.
He offers an insider perspective on how companies and researchers can more effectively work with the organization.

Listen Now

Could Focused Ultrasound Prevent the Development of High-Grade Gliomas?

Researchers at Imperial College London are studying whether treating low-grade brain tumors could prevent them from progressing to high grade.
A Foundation Global Intern is helping investigate a range of drugs in combination with low-intensity focused ultrasound in a preclinical model.

June 2026 Meeting Roundup

Five recent meetings included focused ultrasound presentations.
See reports from ASCO, ASSFN, ISTU, and more.

See the Reports

Focused Ultrasound Intellectual Property Update: Second Quarter 2026

The Foundation tracks focused ultrasound patents and patent applications in the US.
Sixteen new patents have been issued since the beginning of April.

See the List

Forwarded this email by a friend? Sign up to receive these emails here.

And Don't Miss

New Clinical Society Launched by the Foundation | Join IFUS Today!

Focused Ultrasound for Back Pain | FUSMobile Surpasses 1,000 Patients Treated with Neurolyser® XR Across Eight Countries

Submit Proposals for Epilepsy Research Funding by August 12 | American Epilepsy Society (AES) Fellows Program

See Recent News

Events

August 16-21, 2026 Gordon Research Conference on In Vivo Ultrasound Imaging - Advances in Translational Applications of Imaging in Disease Diagnosis, Staging and Therapy, Waterville Valley, New Hampshire, USA

September 17-19, 2026 Annual Scientific Meeting of the Canadian Neuromodulation Society, Calgary, Alberta, Canada

September 24-26, 2026 FOCAL+2026: Frontiers in Oncologic Prostate Care and Ablative Local Therapy, San Diego, California, USA

See All Upcoming Events

Do you have news for our newsletter? Tell us about it!

“I think a lot of people view the FDA as a gatekeeper to keep bad stuff out. Its real mission is to get the devices and technologies to patients in the most efficient way possible.”

‒ Matt Myers, PhD

July 30, 2026 – Long-Term FUS Data for Prostate Cancer and more news…

Contact

Terms of Use